Abstract Despite decades of scientific advancement, the majority of global disease burden continues to receive only a fraction of worldwide medical research funding due to market-driven pharmaceutical incentives and shrinking public research budgets. This article examines the widening “10/90 gap” in global healthcare, where diseases affecting billions of
Educational Content
Abstract As public trust in nonprofits continues to decline, blockchain technology is emerging as a structural solution to one of philanthropy’s biggest challenges: transparency. This article examines how traditional nonprofit models, built on delayed reporting, self-reported financial disclosures and opaque fund allocation systems, are increasingly failing to meet
Abstract Despite unprecedented advances in oncology, large segments of cancer research remain critically underfunded because pharmaceutical investment is concentrated primarily on commercially profitable cancer types and treatments. This article examines the structural gaps within modern cancer funding, including the neglect of rare cancers, prevention research, early-detection technologies and underserved
Abstract As philanthropy increasingly shifts toward accountability-driven giving, Social Return on Investment (SROI) is emerging as one of the most important frameworks for measuring whether charitable capital is producing real, measurable change. This article examines the limitations of traditional philanthropy models built primarily on trust, narrative reporting and activity-